Cited by 1,509Chemotherapy-induced cardiotoxicity and mitigationBioactive Compounds and Antitumor AgentsCancer therapeutics and mechanisms

The DOI matches its Crossref record.

Doxorubicin: The Good, the Bad and the Ugly Effect

Carvalho, Cristina, Santos, Renato, Cardoso, Susana, Correia, Sonia, Oliveira, Paulo, Santos, Maria, Moreira, Paula·2009·Current Medicinal Chemistry

DOI 10.2174/092986709788803312

Open this paper in CoChat — free account

Abstract

The anthracycline doxorubicin (DOX) is widely used in chemotherapy due to its efficacy in fighting a wide range of cancers such as carcinomas, sarcomas and hematological cancers. Despite extensive clinical utilization, the mechanisms of action of DOX remain under intense debate. A growing body of evidence supports the view that this drug can be a double-edge sword. Indeed, injury to nontargeted tissues often complicates cancer treatment by limiting therapeutic dosages of DOX and diminishing the quality of patients' life during and after DOX treatment. The literature shows that the heart is a preferential target of DOX toxicity. However, this anticancer drug also affects other organs like the brain, kidney and liver. This review is mainly devoted to discuss the mechanisms underlying not only DOX beneficial effects but also its toxic outcomes. Additionally, clinical studies focusing the therapeutic efficacy and side effects of DOX treatment will be discussed. Finally, some potential strategies to attenuate DOX-induced toxicity will be debated.

Integrity signals

Registry

Crossref · 10.2174/092986709788803312

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 801–900 of 1,000

Sodium nitrate co-supplementation does not exacerbate low dose metronomic doxorubicin-induced cachexia in healthy mice
Campelj, D. G., Debruin, D. A., Timpani, C. A., Hayes, A., Goodman, C. A., & Rybalka, E. (2020) · Scientific Reports · doi:10.1038/s41598-020-71974-z · Cited by 12
Co-Treatments of Edible Curcumin from Turmeric Rhizomes and Chemotherapeutic Drugs on Cytotoxicity and FLT3 Protein Expression in Leukemic Stem Cells
Chueahongthong, F., Tima, S., Chiampanichayakul, S., et al. (2021) · Molecules · doi:10.3390/molecules26195785 · Cited by 12
The role of deubiquitinases in cardiovascular diseases: mechanisms and therapeutic implications
Fei, X., Song, C., Cui, J., Li, Y., Lei, X., & Tang, H. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1582049 · Cited by 11
“Therefore, studying its toxic mechanisms and developing targeted prevention or treatment strategies are currently key focuses of both clinical and basic research (87).”
The Effects of Doxorubicin-based Chemotherapy and Omega-3 Supplementation on Mouse Brain Lipids
Bennouna, D., Solano, M., Orchard, T., DeVries, A. C., Lustberg, M. B., & Kopec, R. E. (2019) · Metabolites · doi:10.3390/metabo9100208 · Cited by 10
“However, a growing body of evidence suggests that these drugs can be a double-edge sword, with chemotherapy-induced cognitive impairment (CICI) accompanying increased survival rates [4].”
Background
Hydrazone modified nanoscale metal-organic frameworks as pH responsive nanoplatforms for cancer therapy
Fu, D., Wang, Y., Xu, J. Z., & Wu, H. (2022) · Journal of Solid State Chemistry · doi:10.1016/j.jssc.2022.123029 · Cited by 11
Rab10 protects against DOX-induced cardiotoxicity by alleviating the oxidative stress and apoptosis of cardiomyocytes
Zhang, C., Dan, Q., Lai, S., Zhang, Y., Gao, E., Luo, H., Yang, L., Gao, X., & Lu, C. (2022) · Toxicology Letters · doi:10.1016/j.toxlet.2022.10.005 · Cited by 11
Catalpol Inhibits Autophagy to Ameliorate Doxorubicin-Induced Cardiotoxicity via the AKT-mTOR Pathway
Liu, B., Xie, H., Du, X., Zhou, Y., & Huang, J. (2023) · International Heart Journal · doi:10.1536/ihj.23-062 · Cited by 11
Phosphatidylserine and/or Sialic Acid Modified Liposomes Increase Uptake by Tumor-associated Macrophages and Enhance the Anti-tumor Effect
Xu, Z., Li, J., Yan, N. J., Liu, X., Deng, Y., & Song, Y. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02837-3 · Cited by 11
“Due to DOX's cytotoxic effects, the more drug-containing liposomes the cells ingest, the lower their survival rate [34–37].”
Nanoparticles-encapsulated doxorubicin alleviates drug resistance of osteosarcoma via inducing ferroptosis
Tian, X., Zhang, Y., Zhang, M., Liu, G., Hao, Y., & Liu, W. (2024) · Nanotoxicology · doi:10.1080/17435390.2024.2369602 · Cited by 11
“Upon entrance to the cytoplasm, Dox is transformed into the semiquinone, which stimulates oxidative stress and cell damage (Carvalho et al. 2009).”
Targeted codelivery of doxorubicin and oleanolic acid by reduction responsive hyaluronic acid-based prodrug nano-micelles for enhanced antitumor activity and reduced toxicity
Kong, F., Liu, H., Zhao, C., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134135 · Cited by 11
Ophiopogon japonicus polysaccharide reduces doxorubicin-induced myocardial ferroptosis injury by activating Nrf2/GPX4 signaling and alleviating iron accumulation
Chen, Y., Ma, L., Yan, Y., Wang, X., Cao, L., Li, Y., & Li, M. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13401 · Cited by 14
“It manifests as concentration‑dependent, cumulative and potentially fatal myocardial injury, resulting in severe cardiomyopathy and heart failure (4,5).”
Multifaceted therapeutic potentials of catalpol, an iridoid glycoside: an updated comprehensive review
Hassan, M.-A. M., Fahmy, M. I., Azzam, H. N., Ebrahim, Y. M., El‐Shiekh, R. A., & Aboulmagd, Y. M. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01694-1 · Cited by 12
Immunoproteasome as a Target for Prodrugs
Muli, C. S., Loy, C. A., & Trader, D. J. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c03017 · Cited by 11
Multifaceted Cardioprotective Potential of Reduced Glutathione Against Doxorubicin-Induced Cardiotoxicity via Modulating Inflammation–Oxidative Stress Axis
Negm, A., Mersal, E. A., Dawood, A. F., El‐Azim, A. O. A., Hasan, O., Alaqidi, R., Alotaibi, A., Alshahrani, M., Alheraiz, A., & Shawky, T. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073201 · Cited by 16
“Doxorubicin (DOX) is a common chemotherapeutic agent for many malignancies, including breast malignancies, lymphomas, and leukemias [1–3].”
Exosomal circRNAs: key modulators in breast cancer progression
Liu, G., Liu, Q., Jia, L., Chai, Z., Li, J., Xu, F., & Fan, Y. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02494-w · Cited by 16
Nuclear targeted multimodal 3D-bimetallic Au@Pd nanodendrites promote doxorubicin efficiency in breast cancer therapy
Oladipo, A. O., Unuofin, J. O., Iku, S. I. I., Nkambule, T. T. I., Mamba, B. B., & Msagati, T. A. M. (2021) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2021.103344 · Cited by 11
Advances in plasmonic-based MOF composites, their bio-applications, and perspectives in this field
Lelouche, S. N. K., Biglione, C., & Horcajada, P. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2130245 · Cited by 12
“drug doxorubicin (DOX) (47% loading and 90% entrapment) [163,164].”
Background
Interaction of Doxorubicin Embedded into Phospholipid Nanoparticles and Targeted Peptide-Modified Phospholipid Nanoparticles with DNA
Pronina, V. V., Kostryukova, L. V., Bulko, T. V., et al. (2023) · Molecules · doi:10.3390/molecules28145317 · Cited by 11
“The possible reason for the decrease in G, A, and T peak current signals might be due to the shielding of oxidizable groups of these bases, or a damage of these bases provoked by DOX itself (Figure 4A–C) [1,2,7,46].”
Background
Rituximab-conjugated and doxorubicin-loaded microbubbles combined with ultrasound irradiation inhibits proliferation and induces apoptosis in Raji cell lines
Zhou, S., Zheng, S., Shan, Y., Li, L., Zhang, X., & Wang, C. (2015) · Oncology Reports · doi:10.3892/or.2015.4468 · Cited by 11
Development and in vitro evaluation of doxorubicin and celecoxib co-loaded bone targeted nanoparticles
Kozlu, S., Şahin, A., Ultav, G., et al. (2018) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.02.004 · Cited by 11
Engineering Streptomyces peucetius for Doxorubicin and Daunorubicin Biosynthesis
Shrestha, B., Pokhrel, A. R., Darsandhari, S., et al. (2019) · Environmental chemistry for a sustainable world · doi:10.1007/978-3-030-01881-8_7 · Cited by 11
Biochemical studies on the protective effect of honey against doxorubicin-induced toxicity in BALB/C mice.
Alhumaydhi, F. A. (2020) · PubMed · Cited by 11
In vivo assessment of the cytotoxic, genotoxic and antigenotoxic potential of maná-cubiu (Solanum sessiliflorum Dunal) fruit
Hernandes, L. C., Aissa, A. F., Almeida, M. R., Darin, J. D. C., Rodrigues, E., Batista, B. L., Barbosa, F., Mercadante, A. Z., Bianchi, M. L. P., & Antunes, L. M. G. (2014) · Food Research International · doi:10.1016/j.foodres.2014.02.036 · Cited by 13
BGP-15 Protects against Doxorubicin-Induced Cell Toxicity via Enhanced Mitochondrial Function
Gyöngyösi, A., Csaki, N., Pető, Á., Szőke, K., Fenyvesi, F., Bácskay, I., & Lekli, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065269 · Cited by 10
“Doxorubicin (DOX) is a potent chemotherapeutic agent widely used to treat a variety of cancers [1].”
Background
Bridging scales: A hybrid model to simulate vascular tumor growth and treatment response
Duswald, T., Lima, E. A. B. F., Oden, J. T., & Wohlmuth, B. I. (2023) · Computer Methods in Applied Mechanics and Engineering · doi:10.1016/j.cma.2023.116566 · Cited by 12
Design, synthesis, and cytotoxic activity of 2-amino-1,4-naphthoquinone-benzamide derivatives as apoptosis inducers
Sayahi, M. H., Hassani, B., Mohammadi‐Khanaposhtani, M., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-78468-2 · Cited by 10
The antitumor mechanisms of glabridin and drug delivery strategies for enhancing its bioavailability
Li, C., Wang, Y. T., Zhang, W., Yang, X., Wang, Y., Hou, G., Wang, D., Han, B., & Zhang, Y. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1506588 · Cited by 11
ZSM-5/PEG/DOX nanocarrier for pH-responsive doxorubicin release: Kinetic, isothermal, and cytotoxic studies
Broukanlou, M., Hosseini, S. A., & Pazhang, Y. (2025) · Microporous and Mesoporous Materials · doi:10.1016/j.micromeso.2025.113531 · Cited by 10
Acacetin as a natural cardiovascular therapeutic: mechanisms and preclinical evidence
Zhou, Z., Li, T., Qin, H., Wang, X., He, S., Fan, Z., Ye, Q., & Du, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1493981 · Cited by 11
Stimuli-Responsive Hydrogels from Liquid–Liquid Phase Separations of FUS-Derived Peptides
Rosa, E., Pizzella, M., Cimmino, L., et al. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c15249 · Cited by 10
Synthesis of pentablock and multibranched copolymers bearing poly(ethylene glycol), hyperbranched polyglycidol, and poly( L ‐lactide) with biocompatibility for controlled drug release
Wang, J., Kim, M. H., Kang, D. E., et al. (2012) · Journal of Polymer Science Part A Polymer Chemistry · doi:10.1002/pola.26040 · Cited by 10
ON THE POSSIBILITY OF USING NON-IONIZING ELECTROMAGNETIC RADIATION (MILLIMETER WAVES) IN ONCOLOGY
Kalantaryan, V. P., Martirosyan, R., Babayan, Y., et al. (2020) · Progress In Electromagnetics Research Letters · doi:10.2528/pierl20020301 · Cited by 10
“Doxorubicin and netropsin are widely used in chemotherapy due to their efficacy in fight against a wide range of cancers such as carcinomas, sarcomas, and hematological cancers [19].”
Background
Amphiphilic tumor-targeting chimeric peptide-based drug self-delivery nanomicelles for overcoming drug resistance in cancer by synergistic chemo-photodynamic therapy
Chen, P.-L., Peng, S.-L., Wu, L., et al. (2020) · Journal of Materials Science · doi:10.1007/s10853-020-05084-6 · Cited by 10
Peptide-directed delivery of drug-loaded nanocarriers targeting CD36 overexpressing cells
Zheng, Y., Fang, X., Yang, Y., & Wang, C. (2020) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2020.125970 · Cited by 10
Development of a Polymersome-Based Nanomedicine for Chemotherapeutic and Sonodynamic Combination Therapy
Kim, M., Kim, D., Jang, Y.-H., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021194 · Cited by 10
“Doxorubicin, which intercalates into the DNA double-strand and inhibits the synthesis of DNA, is often selected as a chemotherapeutic drug [9].”
Background
Integrating Network Pharmacology and an Experimental Model to Investigate the Effect of Zhenwu Decoction on Doxorubicin-Induced Heart Failure
Hu, Y., Qu, H., & Zhou, H. (2023) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207326666230413091715 · Cited by 10
Gossypetin mitigates doxorubicin-induced nephrotoxicity: A histopathological and biochemical evaluation
Ijaz, M. U., Alvi, K., Khan, H. A., et al. (2023) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2023.102830 · Cited by 10
Oridonin ameliorates doxorubicin induced-cardiotoxicity via the E2F1/Sirt6/PGC1α pathway in mice
Yu, D., Li, J., Wang, Y., et al. (2023) · Food and Chemical Toxicology · doi:10.1016/j.fct.2023.114050 · Cited by 10
Molecular Investigation of the Antitumor Effects of Monoamine Oxidase Inhibitors in Breast Cancer Cells
Alkhawaldeh, A., & Bardaweel, S. K. (2023) · BioMed Research International · doi:10.1155/2023/2592691 · Cited by 11
“Doxorubicin is associated with dose-dependent cardiac cytotoxicity, which limits its clinical usefulness [37].”
Grape-Derived Polyphenols Prevent Doxorubicin-Induced Blunted EDH-Mediated Relaxations in the Rat Mesenteric Artery: Role of ROS and Angiotensin II
Idris-Khodja, N., Marco, P. D., Farhat, M., Gény, B., & Schini‐Kerth, V. B. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/516017 · Cited by 11
Cardiac Troponin-I (cTnI) a Biomarker of Cardiac Injuries Induced by Doxorubicin Alone and in Combination with Ciprofloxacin, Following Acute and Chronic Dose Protocol in Sprague Dawley Rats
Shahzadi, A., Sönmez, M. I., Allahverdi, O., et al. (2014) · International Journal of Pharmacology · doi:10.3923/ijp.2014.258.266 · Cited by 10
Effects of melatonin and agomelatine on doxorubicin induced anxiety and depression-like behaviors in rats
Aygün, H., & Gül, S. Ş. (2018) · Medical Science and Discovery · doi:10.17546/msd.433289 · Cited by 11
Neuroprotective potential of methanolic extract of Saraca asoca bark against doxorubicin-induced neurotoxicity
Kumar, N., Cheruku, S., Chamallamudi, M., Ramalingayya, G. V., Biswas, S., Gourishetti, K., Nandakumar, K., Devkar, R. A., Mallik, S., & Nampoothiri, M. (2019) · Pharmacognosy Magazine · doi:10.4103/pm.pm_79_18 · Cited by 10
“…cognitive impairment in healthy rodents by the mechanism of neuroinflammation, DNA damage and oxidative stress mediated by central and peripheral activation of inflammatory cytokines [4,9,12] which makes it paramount to circumvent the toxic effect of chemotherapy by antioxidant supplementation.”
Endovascular Ion Exchange Chemofiltration Device Reduces Off-Target Doxorubicin Exposure in a Hepatic Intra-arterial Chemotherapy Model
Yee, C., McCoy, D. B., Yu, J., et al. (2019) · Radiology Imaging Cancer · doi:10.1148/rycan.2019190009 · Cited by 10
Synergistic Effects of a Smac Mimetic with Doxorubicin Against Human Osteosarcoma
Kamata, E., Kawamoto, T., Ueha, T., Hara, H., Fukase, N., Minoda, M., Morishita, M., Takemori, T., Fujiwara, S., Nishida, K., et al. (2017) · Anticancer Research · doi:10.21873/anticanres.12058 · Cited by 10
Immune Checkpoint Blockade Improves Chemotherapy in the PyMT Mammary Carcinoma Mouse Model
Sirait‐Fischer, E., Olesch, C., Fink, A. F., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01771 · Cited by 10
“However, major limitations of chemotherapy remain, foremost non-specific toxicity, and tumor chemoresistance (10, 11).”
Background
A Lateral Flow Device for Point-of-Care Detection of Doxorubicin
Pomili, T., Gatto, F., & Pompa, P. P. (2022) · Biosensors · doi:10.3390/bios12100896 · Cited by 10
“The action mechanism of doxorubicin involves its interaction with DNA at different levels: intercalation between the base pairs, strand breakage, and the inhibition of the topoisomerase II enzyme [1].”
Background
Comparison of pigmentary side effects of taxanes and anthracyclines: an onychoscopic evaluation
Yorulmaz, A., Doğan, M., Artüz, F., et al. (2016) · Cutaneous and Ocular Toxicology · doi:10.3109/15569527.2016.1173698 · Cited by 10
“Eligibility criteria for the study included: (1) having a diagnosis of breast or gastric cancer, (2) having been received 16 weeks of chemotherapy [docetaxel (60 mg/m(2), day 1), cisplatin (60 mg/m(2), day 1) and fluorouracil (500 mg/m(2), days 1–5) every 3 weeks for gastric cancer and either paclitaxel (80–175 mg/m(2…”
Background
Comparison of injectable doxorubicin & its nanodrug complex chemotherapy for the treatment of 4-nitroquinoline-1-oxide induced oral squamous cell carcinoma in rats
Khiavi, M. M., Abdal, K., Abbasi, M. M., et al. (2017) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_542_14 · Cited by 10
NH4Cl treatment prevents doxorubicin-induced myocardial dysfunction in vivo
Huang, X., Liu, Y., Yang, X., et al. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.04.044 · Cited by 10
Carvedilol Phenocopies PGC-1α Overexpression to Alleviate Oxidative Stress, Mitochondrial Dysfunction and Prevent Doxorubicin-Induced Toxicity in Human iPSC-Derived Cardiomyocytes
Uche, N., Dai, Q., Lai, S., Kolander, K. D., Thao, M. T., Schibly, E., Sendaydiego, X., Zielonka, J., & Benjamin, I. J. (2023) · Antioxidants · doi:10.3390/antiox12081585 · Cited by 10
“For decades, the anthracycline antibiotic doxorubicin (DOX) has been used as an effective chemotherapy agent for a wide range of cancers [1,2].”
Background
pH-sensitive peptide hydrogel encapsulating the anti-angiogenesis drug conbercept and chemotherapeutic drug dox as a combination therapy for retinoblastoma
Fan, W. H., Chen, M., Raza, F., et al. (2024) · Materials Advances · doi:10.1039/d3ma01028g · Cited by 9
Nicotinic and Muscarinic Acetylcholine Receptor Agonists Counteract Cognitive Impairment in a Rat Model of Doxorubicin-Induced Chemobrain via Attenuation of Multiple Programmed Cell Death Pathways
Ongnok, B., Prathumsap, N., Chunchai, T., Pantiya, P., Arunsak, B., Chattipakorn, N., & Chattipakorn, S. C. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04145-0 · Cited by 9
“Although doxorubicin (DOX) is a remarkable chemo-therapeutic drug extensively used to treat various types of cancer, it has been well-documented that it causes chemobrain across patients with numerous types of cancer [11, 12].”
Adjuvant Anti-tumor Therapy with Polyphenolic Compounds: A Review
Фанилевич, Г. И., Jiang, J., Beylerli, O., Beilerli, A., Ilyasova, T., Shumadalova, A. V., Bai, Y., Du, W., & Yang, B. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673284605240301035057 · Cited by 9
Modulatory effects of miRNAs in doxorubicin resistance: A mechanistic view
Meinag, F. E., Fatahi, M., Vahedian, V., Maroufi, N. F., Mosayyebi, B., Ahmadi, E., & Rahmati, M. (2024) · Functional & Integrative Genomics · doi:10.1007/s10142-024-01431-x · Cited by 9
“The anti-cancer activity of doxorubicin is due to its intercalation into the DNA double helix or covalent binding to replication and transcription proteins (Carvalho et al. 2009; Alizadeh et al. 2018).”
Cardioprotective Effects of Dapagliflozin and Trimetazidine on Doxorubicin-Induced Cardiotoxicity in Streptozotocin-Induced Type 1 Diabetic Rats via Endoplasmic Reticulum Stress
Öğütveren, M. M., Şatıroğlu, Ö., Özden, Z., Akyıldız, K., Yılmaz, A., Mercantepe, F., Yilmaz, A. S., Koç, H., & Mercantepe, T. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14041315 · Cited by 10
“Doxorubicin (DOXO) is a potent antineoplastic agent in the anthracycline class that inhibits tumor growth by blocking DNA synthesis and replication [18].”
NLRP3 inflammasome-based therapies by natural products: a new development in the context of cancer therapy
Owida, H. A., Abed, A. Y., Altalbawy, F. M. A., Malathi, H., Abbot, V., Jakhonkulovna, S. M., Mohammad, S. I. S., Vasudevan, A., Khalaf, R. M., & Zwamel, A. H. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04030-0 · Cited by 11
“Doxorubicin (DOX) is an effective chemotherapy drug frequently employed in pediatric oncology (Almajidi et al. 2023; Carvalho et al. 2009; Speth et al. 1988; Zhu and Lin 2021).”
Ovarian cancer and the heart: pathophysiology, chemotherapy-induced cardiotoxicity, and new therapeutic strategies
Nair, M., Samidurai, A., Das, A., et al. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01636-z · Cited by 9
NLRP3 inflammasome as a therapeutic target in doxorubicin-induced cardiotoxicity: role of phytochemicals
Zhao, X., Duan, L., Zhao, Q., Lv, X., Tian, N.-Y., Yang, S.-L., & Dong, K. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1567312 · Cited by 9
Enhanced therapeutic efficacy of platinum-doxorubicin nanoparticles on colon and breast cancer cell lines
Kalındemirtaş, F. D., Erdemir, G., & Kariper, A. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04080-4 · Cited by 9
“The Food and Drug Administration (FDA) has recognized that DOX has a significant therapeutic effect and is one of the effective chemotherapy drugs for many cancer types such as breast, prostate, and thyroid (Carvalho et al. 2009).”
Enhancing ferroptosis and inhibiting ABCB1 make the novel aldose reductase inhibitor 5F-E a promising sensitizer in liver cancer
Zheng, Z., Chen, Z., Zhang, C., et al. (2025) · Pharmaceutical Science Advances · doi:10.1016/j.pscia.2025.100088 · Cited by 9
“Doxorubicin is a widely used chemotherapeutic agent for various cancers [21] and has been shown to trigger ferroptosis in tumor cells as well as stimulate the immune response in mice [22].”
Cardiotoxicity in Breast Cancer Therapy: Risks, Mechanisms, and Prevention Strategies
Fitrianti, A. E., Wardani, N. O., Astuti, A., Anggadiredja, K., Amalia, L., Putri, R. A., & Zazuli, Z. (2025) · Medical Sciences · doi:10.3390/medsci13030130 · Cited by 11
“Furthermore, anthracyclines can generate iron-mediated free radicals that may target and harm rapidly proliferating cells [22–24].”
Dysregulated YAP1/Hippo Pathway Contributes to Doxorubicin (ADM) Resistance in Acute Myeloid Leukemia (AML)
Chen, X., Song, Y., Huang, R., et al. (2022) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201023666220617150346 · Cited by 9
Hyperthermia and Doxorubicin Release by Fol-LSMO Nanoparticles Induce Apoptosis and Autophagy in Breast Cancer Cells
Kulkarni-Dwivedi, N., Patel, P. R., Shravage, B. V., Umrani, R. D., Paknikar, K. M., & Jadhav, S. H. (2022) · Nanomedicine · doi:10.2217/nnm-2022-0171 · Cited by 9
Seaweed Sargassum aquifolium extract ameliorates cardiotoxicity induced by doxorubicin in rats
Samir, R., Hassan, E. A., Saber, A. A., Haneen, D. S. A., & Saleh, E. M. R. M. (2023) · Environmental Science and Pollution Research · doi:10.1007/s11356-023-26259-z · Cited by 14
SiO 2 /hyaluronic acid nanoparticles carry CaO 2 , DOX and p53 plasmid to effectively achieve ion interference/chemical/gene multimodal therapy of lung cancer
Yi, Z., Huang, X., Lin, N., Yu, F., Chen, Y.-X., Guan, M.-H., Yi, W., & Lai, F. (2023) · Biomaterials Science · doi:10.1039/d2bm02075k · Cited by 9
Pharmacodynamics modeling based on in vitro 3D cell culture experiments
Gergics, B., Vajda, F., Ládi, A., et al. (2023) · IEEE International Symposium on Applied Computational Intelligence and Informatics (SACI) · doi:10.1109/saci58269.2023.10158623 · Cited by 9
Unveiling the anticancer potential of the ethanolic extract from Trichoderma asperelloides
Oliveira, A., Oliveira, F. D. D., Bráz, A. F., Oliveira, J., Lima-Santos, J., & Dias, A. A. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1398135 · Cited by 7
“…tumors, due to its lack of selectivity, DOX presents many undesirable adverse effects such as stomatitis, gastrointestinal disturbances, nausea, fatigue, alopecia, and cardiotoxicity, which is a major concern during therapy (Carvalho et al., 2009; Meredith and Dass, 2016; Mollaei et al., 2021).”
Background
Investigation of prostate cancer cells using NADH and Tryptophan as biomarker: multiphoton FLIM-FRET microscopy
Rehman, S., O’Melia, M. J., Wallrabe, H. K., et al. (2016) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2220779 · Cited by 9
Effects of doxorubicin on the structural and morphological characterization of solid lipid nanoparticles (SLN) using small angle neutron scattering (SANS) and small angle X-ray scattering (SAXS)
Yokaichiya, F., Schmidt, C., Storsberg, J., et al. (2017) · Physica B Condensed Matter · doi:10.1016/j.physb.2017.12.036 · Cited by 9
Suppressive efficiency of Kojic acid from Aspergillus tamarii MM11 against HepG-2 cell line derived from human liver cancer
El‐Metwally, M. M., ElBealy, E. R., Beltagy, D. M., et al. (2020) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v19i8.14 · Cited by 9
“There was a study suggested the ability of Kojic acid to cause mutations in salmonella bacteria [3].”
Background
Magnetic Particles with Polymeric Shells Bearing Cholesterol Moieties Sensitize Breast Cancer Cells to Low Doses of Doxorubicin
Markiewicz, K. H., Niemirowicz-Laskowska, K., Szymczuk, D., Makarewicz, K., Misztalewska‐Turkowicz, I., Wielgat, P., Majcher, A. M., Milewska, S., Car, H., & Wilczewska, A. Z. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094898 · Cited by 9
“The major side effect of DOX is significant cardiac toxicity, which limits the long-term use of the drug [13].”
Background
Cell-Secreted Vesicles: Novel Opportunities in Cancer Diagnosis, Monitoring and Treatment
Catoni, C., Paolo, V. D., Rossi, E. M. C., Quintieri, L., & Zamarchi, R. (2021) · Diagnostics · doi:10.3390/diagnostics11061118 · Cited by 9
Doxorubicin-Induced Fetal Mesangial Cell Death Occurs Independently of TRPC6 Channel Upregulation but Involves Mitochondrial Generation of Reactive Oxygen Species
Matthews, A. T., Soni, H., Robinson-Freeman, K. E., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147589 · Cited by 9
Identification of new candidate biomarkers to support doxorubicin treatments in canine cancer patients
Walters, K., Stornetta, A., Jacobs, F. C., et al. (2021) · BMC Veterinary Research · doi:10.1186/s12917-021-03062-x · Cited by 9
“The intensity of these adverse events varies from patient to patient [21, 22].”
Background
Development and Evaluation of Core-Shell Nanocarrier System for Enhancing the Cytotoxicity of Doxorubicin/Metformin Combination Against Breast Cancer Cell Line
Ibrahim, A., Khalil, I. A. H., & El-sherbiny, I. M. (2022) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2022.05.018 · Cited by 9
Simvastatin Coadministration Modulates the Electrostatically Driven Incorporation of Doxorubicin into Model Lipid and Cell Membranes
Bartkowiak, A., Nazaruk, E., Gajda, E., et al. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00724 · Cited by 9
Tan IIA inhibits H1299 cell viability through the MDM4‑IAP3 signaling pathway
Zu, Y., Wang, J., Wei, P., & Sun, W. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8152 · Cited by 9
“As a Food and Drug Administration-approved chemotherapeutic drug, DOX is used to treat a wide range of types of cancer (36,37).”
Retracted
Angelica gigas Nakai Has Synergetic Effects on Doxorubicin-Induced Apoptosis
Jeon, Y.-J., Shin, J.-I., Lee, S., et al. (2018) · BioMed Research International · doi:10.1155/2018/6716547 · Cited by 9
Controllable Growth and Assembling Strategies Based on Nanomaterials for Targeted and Precise Therapy of Malignant Cancers
Song, X., Zhang, H., Yan, T., et al. (2020) · Chinese Journal of Chemistry · doi:10.1002/cjoc.202000336 · Cited by 9
Metallo-Liposomes Derived from the [Ru(bpy)3]2+ Complex as Nanocarriers of Therapeutic Agents
Moyá, M. L., Ostos, F. J., Moreno, I., et al. (2021) · Chemosensors · doi:10.3390/chemosensors9050090 · Cited by 9
“This antibiotic is an anthracycline (see Figure 2) frequently used in the treatment of carcinomas, sarcomas and leukemia [33].”
Background
Mitigating off-target distribution and enhancing cytotoxicity in breast cancer cells with alpha-ketoglutaric acid-modified Fe/Mg-CA nanoparticles
Haque, S. T., Karim, M. E., Othman, I., & Chowdhury, E. H. (2022) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-022-00571-1 · Cited by 9
Interaction of Daunomycin with Acetylated Chromatin
Sprigg, L., Li, A., Choy, F. Y. M., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1007853 · Cited by 9
N-(2-hydroxy phenyl) acetamide ameliorate inflammation and doxorubicin-induced nephrotoxicity in rats
阿部, 麻., Lubbad, L. I., Simjee, S. U., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110741 · Cited by 8
Hydroxyapatite Nanocrystals Integrated into Mesoporous Silica for Sustained Delivery of Doxorubicin
Bessa, I. A. A., Cruz, J. V. R., Silva, A. F. M. D., et al. (2023) · ACS Applied Nano Materials · doi:10.1021/acsanm.3c04519 · Cited by 8
miRNA Expression Profiles in Isolated Ventricular Cardiomyocytes: Insights into Doxorubicin-Induced Cardiotoxicity
Domínguez-Romero, Y., Montoya-Ortiz, G., Novoa-Herrán, S. S., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105272 · Cited by 8
“One of the most widely used and effective treatments for cancer is Doxorubicin (DOX); however, previous studies have shown that this therapy can induce cytotoxicity [1,2].”
Background
Co-Encapsulation of Paclitaxel and Doxorubicin in Liposomes Layer by Layer
Mota-Díaz, I. I., Douda, J., García‐López, P., Cabrera‐Becerra, S. E., Álvarez, M. Á. G., Rodríguez, R. J., Jurado, R., & López‐Sánchez, P. (2024) · Colloids and Interfaces · doi:10.3390/colloids8040042 · Cited by 10
Perturbation-specific transcriptional mapping for unbiased target elucidation of antibiotics
Romano, K. P., Bagnall, J., Warrier, T., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2409747121 · Cited by 8
Peptide hydrogel-drug conjugates for tailored disease treatment
Cauwenbergh, T., Ballet, S., & Martin, C. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101423 · Cited by 8
Doxorubicin functionalized metallic nanoparticles for anticancer and antibacterial applications
Yeşil, İ., Atmaca, H., Değirmenci, S., et al. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.106653 · Cited by 8
Water-soluble porphyrin-mediated enhanced photodynamic and chemotherapy employing doxorubicin for breast cancer
Mokhtar, A., Mohamed, T. A., Eigza, A. O., et al. (2025) · Lasers in Medical Science · doi:10.1007/s10103-025-04466-z · Cited by 8
Doxorubicin‐Induced Cardiotoxicity: Comprehensive Pathway Insights and Advanced Preclinical Therapeutics
Sharma, S., Parashar, M., Lal, K., Naik, M., & Tanwar, S. S. (2026) · Journal of Applied Toxicology · doi:10.1002/jat.70131 · Cited by 9
“Doxorubicin is an anthracycline drug, originally derived from Streptomyces peucetius var. caesius , and is widely used to treat cancers including breast, lung, ovarian, and lymphoma (Rawat et al. 2021; Carvalho et al. 2009).”
Functional Muscle Transfer after Oncologic Extremity Resection
Hassan, A. M., Tesfaye, E. A., Rashiwala, A., et al. (2022) · Journal of Reconstructive Microsurgery · doi:10.1055/a-1887-7530 · Cited by 8
Doxorubicin-induced testicular toxicity: possible underlying mechanisms and promising pharmacological treatments in experimental models.
Alafifi, S. A., Wahdan, S., Elsherbiny, D. A., & Azab, S. S. (2022) · Archives of Pharmaceutical Sciences Ain Shams University · doi:10.21608/aps.2022.155127.1098 · Cited by 8
Amelioration of Doxorubicin-Induced Cognitive Impairment by Quercetin in a Rat Model of Breast Cancer
Ramalingayya, G. V., John, J., Gourishetti, K., et al. (2022) · Revista Brasileira de Farmacognosia · doi:10.1007/s43450-022-00341-y · Cited by 8
“The cytotoxic effects of DOX adversely affect the normal cells resulting in the toxicities of the heart, liver, kidneys, and brain (Carvalho et al. 2009).”
Background
Polymeric core-crosslinked particles prepared via a nanoemulsion-mediated process: from particle design and structural characterization to in vivo behavior in chemotherapy
Fujii, S. (2023) · Polymer Journal · doi:10.1038/s41428-023-00793-6 · Cited by 8
“accumulate in all healthy organs at high levels (especially in the liver), causing severe side effects [4].”
Background
Effectiveness of Nonfunctionalized Graphene Oxide Nanolayers as Nanomedicine against Colon, Cervical, and Breast Cancer Cells
Hatshan, M. R., Saquib, Q., Siddiqui, M. A., Faisal, M., Ahmad, J., Al-Khedhairy, A. A., Shaik, M. R., Khan, M., Wahab, R., Matteis, V. D., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119141 · Cited by 8
Glucose-derived carbon dots for targeted delivery of doxorubicin in cancer therapy
Dubey, N., Ramteke, S., Jain, N. K., Dutta, T., & Koner, A. L. (2023) · New Journal of Chemistry · doi:10.1039/d3nj02843g · Cited by 9
Zinc oxide nanoparticles regulate NF-kB expression and restrict inflammation response in doxorubicin-induced kidney injury in rats
Elgohary, A., Metwalli, F., Mostafa, N. Y., Refaat, M., & El-Khawaga, O. Y. (2023) · Toxicology and Environmental Health Sciences · doi:10.1007/s13530-023-00194-5 · Cited by 9
Cold plasma-treated medium preferentially eliminates doxorubicin-resistant osteosarcoma cells
Tornín, J., Gallego, B., Rey, V., Murillo, D., Huergo, C., Rodríguez, A., Canal, C., & Rodrı́guez, R. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.10.394 · Cited by 8

Authors: Carvalho, C., Santos, R., Cardoso, S., Correia, S., Oliveira, P., Santos, M., & Moreira, P.
Affiliations: Centro de Neurociências e Biologia Celular (PT)
Corresponding author: Moreira, Paula
ORCID: Carvalho, Cristina
Santos, Renato
Cardoso, Susana
Oliveira, Paulo
Santos, Maria
Moreira, Paula
Venue: Current Medicinal Chemistry
Publisher: Bentham Science Publishers Ltd.
Published: 2009-09-01
Volume: 16
Issue: 25
Pages: 3267-3285
ISSN: 0929-8673 (ISSN-L)
DOI: 10.2174/092986709788803312
OpenAlex: W2102897174
Cited by: 1,509
References: 0
Citations by year: 2026: 102 · 2025: 147 · 2024: 174 · 2023: 169 · 2022: 153 · 2021: 150 · 2020: 120 · 2019: 85 · 2018: 84 · 2017: 53 · 2016: 63 · 2015: 62 · 2014: 43 · 2013: 35 · 2012: 29
FWCI: 14.12
Type: journal article
Language: en
Open access: closed
Locations: Current Medicinal Chemistry (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer therapeutics and mechanisms
Keywords: doxorubicin, anthracyclines, cardiotoxicity, drug toxicity mechanisms, anticancer mechanism, neurotoxicity, nephrotoxicity, hepatotoxicity, chemotherapy side effects
MeSH terms: Antibiotics, Antineoplastic, Doxorubicin, Humans, Molecular Conformation, Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Doxorubicin: The Good, the Bad and the Ugly Effect

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks